These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 1646908)

  • 1. C-myc as an inducer of polycystic kidney disease in transgenic mice.
    Trudel M; D'Agati V; Costantini F
    Kidney Int; 1991 Apr; 39(4):665-71. PubMed ID: 1646908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transgenic overexpression of prothymosin alpha induces development of polycystic kidney disease.
    Li KJ; Shiau AL; Chiou YY; Yo YT; Wu CL
    Kidney Int; 2005 May; 67(5):1710-22. PubMed ID: 15840017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disappearance of polycystic kidney disease in revertant c-myc transgenic mice.
    Trudel M; Chrétien N; D'Agati V
    Mamm Genome; 1994 Mar; 5(3):149-52. PubMed ID: 8199402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polycystic kidney disease in SBM transgenic mice: role of c-myc in disease induction and progression.
    Trudel M; Barisoni L; Lanoix J; D'Agati V
    Am J Pathol; 1998 Jan; 152(1):219-29. PubMed ID: 9422539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal expression of a transforming growth factor-alpha transgene accelerates the progression of inherited, slowly progressive polycystic kidney disease in the mouse.
    Gattone VH; Kuenstler KA; Lindemann GW; Lu X; Cowley BD; Rankin CA; Calvet JP
    J Lab Clin Med; 1996 Feb; 127(2):214-22. PubMed ID: 8636651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-myc-induced apoptosis in polycystic kidney disease is Bcl-2 and p53 independent.
    Trudel M; Lanoix J; Barisoni L; Blouin MJ; Desforges M; L'Italien C; D'Agati V
    J Exp Med; 1997 Dec; 186(11):1873-84. PubMed ID: 9382886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of PKD1 causes polycystic kidney disease.
    Thivierge C; Kurbegovic A; Couillard M; Guillaume R; Coté O; Trudel M
    Mol Cell Biol; 2006 Feb; 26(4):1538-48. PubMed ID: 16449663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated c-myc protooncogene expression in autosomal recessive polycystic kidney disease.
    Cowley BD; Smardo FL; Grantham JJ; Calvet JP
    Proc Natl Acad Sci U S A; 1987 Dec; 84(23):8394-8. PubMed ID: 3479800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The master regulators Myc and p53 cellular signaling and functions in polycystic kidney disease.
    Kurbegovic A; Trudel M
    Cell Signal; 2020 Jul; 71():109594. PubMed ID: 32145315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A model of polycystic kidney disease in SBM transgenic mice.
    Trudel M; D'Agati V
    Contrib Nephrol; 1992; 97():47-59. PubMed ID: 1321706
    [No Abstract]   [Full Text] [Related]  

  • 11. Overexpression of exogenous kidney-specific Ngal attenuates progressive cyst development and prolongs lifespan in a murine model of polycystic kidney disease.
    Wang E; Chiou YY; Jeng WY; Lin HK; Lin HH; Chin HJ; Leo Wang CK; Yu SS; Tsai SC; Chiang CY; Cheng PH; Lin HJ; Jiang ST; Chiu ST; Hsieh-Li HM
    Kidney Int; 2017 Feb; 91(2):412-422. PubMed ID: 28341240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute kidney injury induces hallmarks of polycystic kidney disease.
    Kurbegovic A; Trudel M
    Am J Physiol Renal Physiol; 2016 Oct; 311(4):F740-F751. PubMed ID: 27488998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parallel analysis of mRNA and microRNA microarray profiles to explore functional regulatory patterns in polycystic kidney disease: using PKD/Mhm rat model.
    Dweep H; Sticht C; Kharkar A; Pandey P; Gretz N
    PLoS One; 2013; 8(1):e53780. PubMed ID: 23326503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine models of polycystic kidney disease: molecular and therapeutic insights.
    Guay-Woodford LM
    Am J Physiol Renal Physiol; 2003 Dec; 285(6):F1034-49. PubMed ID: 14600027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glomerulosclerosis and renal cysts in mice transgenic for the early region of SV40.
    MacKay K; Striker LJ; Pinkert CA; Brinster RL; Striker GE
    Kidney Int; 1987 Dec; 32(6):827-37. PubMed ID: 2828752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney-specific inactivation of the KIF3A subunit of kinesin-II inhibits renal ciliogenesis and produces polycystic kidney disease.
    Lin F; Hiesberger T; Cordes K; Sinclair AM; Goldstein LS; Somlo S; Igarashi P
    Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5286-91. PubMed ID: 12672950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting of the rasT24 oncogene to the proximal convoluted tubules in transgenic mice results in hyperplasia and polycystic kidneys.
    Schaffner DL; Barrios R; Massey C; Bañez EI; Ou CN; Rajagopalan S; Aguilar-Cordova E; Lebovitz RM; Overbeek PA; Lieberman MW
    Am J Pathol; 1993 Apr; 142(4):1051-60. PubMed ID: 8097368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autophagy induction promotes renal cyst growth in polycystic kidney disease.
    Lee EJ; Ko JY; Oh S; Jun J; Mun H; Lim CJ; Seo S; Ko HW; Kim H; Oh YK; Ahn C; Kang M; Kim MJ; Yoo KH; Oh GT; Park JH
    EBioMedicine; 2020 Oct; 60():102986. PubMed ID: 32949996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiorgan mRNA misexpression in murine autosomal recessive polycystic kidney disease.
    Gattone VH; Ricker JL; Trambaugh CM; Klein RM
    Kidney Int; 2002 Nov; 62(5):1560-9. PubMed ID: 12371956
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.